589 related articles for article (PubMed ID: 25388377)
1. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
3. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
5. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.
Hong Y; Li HF; Skeie GO; Romi F; Hao HJ; Zhang X; Gao X; Owe JF; Gilhus NE
J Neuroimmunol; 2016 Sep; 298():51-7. PubMed ID: 27609275
[TBL] [Abstract][Full Text] [Related]
7. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation.
Nagappa M; Mahadevan A; Gangadhar Y; Patil SA; Bokolia S; Bindu PS; Sinha S; Taly AB
Acta Neurol Scand; 2019 May; 139(5):428-437. PubMed ID: 30693486
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
10. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
11. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
12. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
13. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
15. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
16. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
[TBL] [Abstract][Full Text] [Related]
18. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens.
Zisimopoulou P; Brenner T; Trakas N; Tzartos SJ
Autoimmun Rev; 2013 Jul; 12(9):924-30. PubMed ID: 23537507
[TBL] [Abstract][Full Text] [Related]
19. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG
J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329
[TBL] [Abstract][Full Text] [Related]
20. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]